Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2014; 20(16): 4618-4625
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4618
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4618
Juice and its components | Cell line tested | Observation/result | Ref. |
Whole/crude pomegranate juice | HT-29 human colon cancer cells | Inhibition of NFκB activation, AKT activity and COX-2 expression | [18,19] |
Inhibition of COX-2 expression leading to the prevention of initiation and progression of colon cancer | [24] | ||
Ellagitannins of pomegranate juice | Caco-2 cells | Apoptosis of Caco-2 cells through the mitochondrial pathway | [16] |
Punicalagin of pomegranate juice | HT-29 colon cancer cells | Down regulation of the anti-apoptotic Bc1-XL protein was achieved with 30 μmol/L ellagic acid and 100 μmol/L punicalaginInduction of intrinsic pathway of apoptosis in colon cancer cells | [25] |
Urolithins A and C of pomegranate juice | HT-29 human colon cancer cells | Inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1-mediated ethoxyresorufin-O-deethylase activityIC50 values range: 56.7-74.8 μmol/LInduction of apoptosis in a time- and dose-dependent manner | [15] |
Naringenin of citrus juice | HT-29 colon cancer cells | Inhibition of cell proliferation at doses greater than 0.71 mmol/L demonstrated using colorimetric assay | [36] |
Limonoids of citrus juice | Human colon cancer cell lines | Induction of apoptosis and cytotoxic effects in MCF-7 and SKOV-3 cells at high concentrations | [37] |
Flavonoids of citrus juice | Cell cycle blockade in G0/G1 phase | ||
Tangeritin | Human colorectal carcinoma-COLO 205 cells | Reduced levels of cyclins (A, D1 and E)Decreased phosphorylation of RbIncreased production of cyclin-dependent kinase inhibitors, p53, p21, p27 | [38] |
Luteolin | Inhibition of growth of colon cancer cells | [39] | |
Nobiletin | Inhibition of growth of colon cancer cells |
Juice and its components | Animal model used | Observation/result | Ref. |
Whole/crude pomegranate juice | Male F-344 rats | Histopathological studies of azoxymethane-induced rat colonSignificant decrease in number of large cryptic fociIncrease in feed intake and weight gainProtective effects against cancer cachexiaThree times higher activity of GSTAnti oxidative actions by scavenging free radicals | [29] |
Mice | Inhibition of JNK1/2 activity, p38, ERK1/2 and COX-2 expression | [30] | |
Apigenin of citrus juice | Azoxymethane-induced CF-1 mice | Reduced ODC activity and ACF numbersReduced tumor formation | [39] |
Mixture of apigenin and epigallocathechin-gallate | Patients with colorectal neoplasia | Suppressed colon neoplasia recurrence rates | [41] |
Hesperitin of citrus juice | DMH-treated male Wistar rats | Reduced number of ACF at a dose of 20 mg/kg | [40] |
Nobiletin of citrus juice | Azoxymethane-treated male F344 rats | Decreased PGE2 production in ratsChemo-preventive agents at the promotion stage of colon carcinogenesis | [43] |
Naringenin of citrus juice | Azoxymethane-injected Sprague Dawley rats | Reduced levels of COX-2 and iNOSDecrease in proliferation of colon cancer cells | [45,46] |
- Citation: Jaganathan SK, Vellayappan MV, Narasimhan G, Supriyanto E. Role of pomegranate and citrus fruit juices in colon cancer prevention. World J Gastroenterol 2014; 20(16): 4618-4625
- URL: https://www.wjgnet.com/1007-9327/full/v20/i16/4618.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i16.4618